rafaelpharma.com

GENERAL
META
HTML
LINK ANALYSIS
SERVER
IP

Rafaelpharma.com recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.

Website Age n/a
Alexa Rank no-data
Country Canada
IP Address 151.101.130.159

META INFORMATION

Title

Innovative Cancer Therapies | Rafael Pharmaceuticals

Description

Rafael Pharmaceuticals is developing innovative cancer therapies for the most intractable forms of the disease including AML, Burkitts & pancreatic cancer.

Keywords

Content Type

utf-8

No	Meta Name	Value
1	viewport	width=device-width,initial-scale=1.0,minimum-scale=1.0
2	robots	index, follow

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 16.65 %

rafaelpharma.com has a website text/code ratio of 16.65 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

H14
H218
H37
H41
H52
H60

No	Text
1	To save a life ıs to save a universe
2	Cancer metabolism
3	Breakthrough therapies
4	Mission

No	Text
1	Vision
2	Cpı-613® (devimistat)
3	Dr. sol j. barer, ph.d.
4	Chi van dang, m.d., ph.d.
5	Jorge cortes, m.d.
6	Steven ı. park, m.d.
7	Dafna bar-sagi, ph.d.
8	Philip a. philip, m.d., ph.d., frcp
9	Greg s*****za, m.d., ph.d.
10	World cla*** team
11	ın the news
12	Rafael pharmaceuticals to present phase 1 data on cpı-613® (devimistat) in patients with locally advanced or metastatic pancreatic cancer at american society of clinical oncology (asco) 2020 virtual scientific program
13	Rafael pharmaceuticals announces ın vivo study to evaluate the effects of cpı-613® (devimistat) in combination with azacitidine and venetoclax on acute myeloid leukemia models
14	Rafael pharmaceuticals enters into research collaboration with roswell park comprehensive cancer center to evaluate the effects of cpı-613® (devimistat) on esophageal cancer
15	Rafael pharmaceuticals receives approvals to open trial sites in ındia and canada for pivotal phase 3 trial (armada 2000) of cpı-613® (devimistat) in patients with relapsed or refractory acute myeloid leukemia (aml)
16	Rafael pharmaceuticals enrolls more than 75% of patients needed for pivotal phase 3 trial (avenger 500) of cpı-613 ️ (devimistat) for patients with metastatic pancreatic cancer
17	Rafael pharmaceuticals appoints sanjay sehgal, ph.d., to chief regulatory affairs and quality a***urance officer
18	Pancreatic cancer action network

No	Text
1	Learn more about our clinical trials:
2	Advisor to the board of directors, rafael pharmaceuticals
3	Chairman of rafael’s scientific and medical advisory boards
4	Acute myeloid leukemia advisor
5	Lymphoma advisor
6	Pancreatic cancer advisor
7	Nobel prize in physiology and medicine

No	Text
1	Rafael is a proud sponsor of the pancreatic cancer action network

No	Text
1	Quick links
2	Stay in touch

Text Styling

STRONG0
B0
EM1
I0
U0
CITE0

No	Text
1	Rafael is a proud sponsor of the Pancreatic Cancer Action Network

LINK ANALYSIS

Total Link Count: 77

Internal Link Count : 61

No	Text	Type
1	-	image
2	About	text
3	Company Overview	text
4	Mission and Vision	text
5	Letter from our Chairman	text
6	Research and Development	text
7	Cancer Metabolism	text
8	AMD Platform	text
9	CPI-613® (devimistat)	text
10	Pipeline	text
11	Leaders***p	text
12	Executive Management	text
13	Board of Directors	text
14	Medical Advisors	text
15	Scientific Advisors	text
16	Clinical Trial Enrollment	text
17	Contact Us	text
18	News & Investors	text
19	Press Releases	text
20	News Coverage	text
21	Press Kit	text
22	Request Information	text
23	Scientific Exchange	text
24	Publications	text
25	Conference Presentations	text
26	Work With Us	text
27	Partnering	text
28	Careers	text
29	Culture	text
30	Compa***ionate Use	text
31	Clinical Trial Enrollment	text
32	Contact Us	text
33	Company Overview	text
34	Learn More	text
35	AMD Platform	text
36	https://rafaelpharma.com/wp-content/uploads/FINAL_Rafael-MOA-Video-3D.mp4	text
37	Clinical Trial 18-443: Patients with Burkitt’s Lymphoma/Leukemia or High-Grade B-cell Lymphoma	text
38	Clinical Trial AML003: Older Patients with Acute Myeloid Leukemia (AML) – Relapsed or Refractory	text
39	Clinical Trial PANC003: Patients with Metastatic Adenocarcinoma of the Pancreas	text
40	View All Clinical Trials	text
41	Learn More	text
42	Board of Directors	text
43	Medical Advisors	text
44	Scientific Advisors	text
45	View All Press	text
46	-	image
47	-	empty
48	(609) 409-7050	text
49	info@rafaelpharma.com	text
50	Home	text

External Link Count : 16

No	Text	Type
1	Rafael Pharmaceuticals to Present Phase 1 Data on CPI-613® (Devimistat) in Patients with Locally Advanced or Metastatic Pancreatic Cancer at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program	text
2	Read More	text
3	Rafael Pharmaceuticals Announces In Vivo Study to Evaluate the Effects of CPI-613® (Devimistat) in Combination with Azacitidine and Venetoclax on Acute Myeloid Leukemia Models	text
4	Read More	text
5	Rafael Pharmaceuticals Enters into Research Collaboration with Roswell Park Comprehensive Cancer Center to Evaluate the Effects of CPI-613® (Devimistat) on Esophageal Cancer	text
6	Read More	text
7	Rafael Pharmaceuticals Receives Approvals to Open Trial Sites in India and Canada for Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)	text
8	Read More	text
9	Rafael Pharmaceuticals Enrolls More Than 75% of Patients Needed for Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ️ (devimistat) for Patients with Metastatic Pancreatic Cancer	text
10	Read More	text
11	Rafael Pharmaceuticals Appoints Sanjay Sehgal, Ph.D., to Chief Regulatory Affairs and Quality a***urance Officer	text
12	Read More	text
13	Rafael Pharmaceuticals, Inc. 1 Duncan Drive Cranbury, NJ 08512	text
14	LinkedIn	text
15	Facebook	text
16	Twitter	text

Nofollow Link Count : 5

No	Text	Type
1	-	empty
2	Rafael Pharmaceuticals, Inc. 1 Duncan Drive Cranbury, NJ 08512	text
3	LinkedIn	text
4	Facebook	text
5	Twitter	text

Title Link Count : 0

WEBSITE SERVER INFORMATION

Service Provider (ISP)
Fastly
Hosted IP Address
151.101.130.159
Hosted Country
Canada
Host Region
Quebec , Montreal
Latitude and Longitude
45.5017 : -73.5673

WEBSITES USING THE SAME IP ADDRESS

Icon	Domain	IP	Alexa Rank
	Trainual.com	151.101.130.159	100.467
	Earnestcapital.com	151.101.130.159	288.034
	Kayakrepublic.dk	151.101.130.159	1.162.954
	Zetterberg.com	151.101.130.159	1.336.455
	Avenueedmonton.com	151.101.130.159	905.111
	Audiomachine.com	151.101.130.159	640.211
	Mechanicaldesign101.com	151.101.130.159	5.451.303
	Adem.arkansas.gov	151.101.130.159	16.717
	War.com	151.101.130.159	3.649.250
	Insomniacpress.com	151.101.130.159	-
	Aquaculture.org.nz	151.101.130.159	2.601.516

WEBSITES USING THE SAME C CLASS IP

Icon	Domain	IP	Alexa Rank
	Netballnz.co.nz	151.101.130.114	2.802.247
	Allaboutthejersey.com	151.101.130.125	312.909
	Jewelsfromthecrown.com	151.101.130.125	2.242.837
	Centerlinesoccer.com	151.101.130.125	-
	Nordstrom.com	151.101.130.132	1.357
	Foursquare.com	151.101.130.132	-
	Audacy.com	151.101.130.132	-
	Vix.com	151.101.130.132	-
	Centralrestaurant.com	151.101.130.133	210.756
	Benditofutbol.com	151.101.130.133	14.084
	Gardenersworld.com	151.101.130.133	62.187
	Group.softbank	151.101.130.133	77.312
	Dpgmedia.be	151.101.130.133	29.437
	Menupages.com	151.101.130.133	53.251
	Considerable.com	151.101.130.133	109.858
	Vogue.es	151.101.130.133	72.900
	Sharespost.com	151.101.130.133	78.813
	Anchor.fm	151.101.130.133	2.792
	Harvard.edu	151.101.130.133	-
	Thoughtco.com	151.101.130.137	2.468
	Updates.gizmodo.com	151.101.130.166	1.728
	Twitch.tv	151.101.130.167	46
	M.twitch.tv	151.101.130.167	46
	Wired.com	151.101.130.194	2.623
	Playbuzz.com	151.101.130.2	14.305
	Wikihow.tech	151.101.130.202	61.033
	Wonderfulmind.co.kr	151.101.130.207	216.214
	Rochester.kidsoutandabout.com	151.101.130.216	-
	Tutor2U.net	151.101.130.217	19.111
	Clicksend.com	151.101.130.217	42.095
	Advancedbackgroundchecks.com	151.101.130.217	98.578
	Buttercms.com	151.101.130.217	51.357
	Basicattentiontoken.org	151.101.130.217	16.803
	Fubotv.com	151.101.130.217	5.436.482
	Mdsol.com	151.101.130.49	113.635
	Tubemogul.com	151.101.130.49	43.136
	Ticketweb.co.uk	151.101.130.87	5.416.408
	Homify.com	151.101.130.9	54.698

COUNTRIES More

Last Updated Websites

Last viewed websites

LASTEST ANALYZED WEBSITES

HOW DO I REMOVE MY WEBSITE ?

REPORT THIS WEBSITE

Website Analysis

SHARE THIS ANALYSIS

Analyzing...